Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects

• প্রধান লেখক: Maria Isabel Ramos Saraiva (Author), Larissa Karine Leite Portocarrero (Author), Marcella Amaral Horta Barbosa Vieira (Author), Bethania Cabral Cavalli Swiczar (Author), Andrezza Telles Westin (Author)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Sociedade Brasileira de Dermatologia, 2018-08-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract: Background: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil...